These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 18094340

  • 1. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation.
    Jennings DL, Taber DJ.
    Ann Pharmacother; 2008 Jan; 42(1):116-20. PubMed ID: 18094340
    [Abstract] [Full Text] [Related]

  • 2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period.
    Formica RN, Friedman AL, Lorber MI, Bia MJ.
    Transplant Proc; 2004 Nov; 36(9):2675-8. PubMed ID: 15621121
    [Abstract] [Full Text] [Related]

  • 4. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T.
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
    Epstein BJ, Gums JG.
    Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
    [Abstract] [Full Text] [Related]

  • 6. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM, Sanoski CA, Spinler SA.
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [Abstract] [Full Text] [Related]

  • 7. Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
    Catapano F, Chiodini P, De Nicola L, Minutolo R, Zamboli P, Gallo C, Conte G.
    Am J Kidney Dis; 2008 Sep; 52(3):475-85. PubMed ID: 18468748
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines.
    Gales BJ, Bailey EK, Reed AN, Gales MA.
    Ann Pharmacother; 2010 Feb; 44(2):360-6. PubMed ID: 20086184
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin blockade is associated with early graft dysfunction after live donor renal transplantation.
    Stevens KK, Patel RK, Clancy M, Jardine AG.
    Transplantation; 2010 Mar 27; 89(6):707-9. PubMed ID: 20010330
    [Abstract] [Full Text] [Related]

  • 10. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
    Weir MR, Rolfe M.
    Clin J Am Soc Nephrol; 2010 Mar 27; 5(3):531-48. PubMed ID: 20150448
    [Abstract] [Full Text] [Related]

  • 11. Addition of spironolactone to dual blockade of renin angiotensin system dramatically reduces severe proteinuria in renal transplant patients: an uncontrolled pilot study at 6 months.
    González Monte E, Andrés A, Polanco N, Toribio MJ, Santana R, Gutiérrez Martínez E, González J, Ramírez E, Hernández A, Morales E, Praga M, Morales JM.
    Transplant Proc; 2010 Oct 27; 42(8):2899-901. PubMed ID: 20970564
    [Abstract] [Full Text] [Related]

  • 12. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP.
    Cardiol Rev; 2006 Oct 27; 14(2):81-7. PubMed ID: 16493245
    [Abstract] [Full Text] [Related]

  • 13. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
    Ruilope LM.
    Acta Diabetol; 2005 Apr 27; 42 Suppl 1():S33-41. PubMed ID: 15868118
    [Abstract] [Full Text] [Related]

  • 14. The cardiovascular continuum and renin-angiotensin-aldosterone system blockade.
    Dzau V.
    J Hypertens Suppl; 2005 Apr 27; 23(1):S9-17. PubMed ID: 15821452
    [Abstract] [Full Text] [Related]

  • 15. Is there added value to adding ARB to ACE inhibitors in the management of CKD?
    Cohen DL, Townsend RR.
    J Am Soc Nephrol; 2009 Aug 27; 20(8):1666-8. PubMed ID: 18776118
    [Abstract] [Full Text] [Related]

  • 16. Modulation of the renin-angiotensin-aldosterone system and cough.
    Lacourcière Y, Lefebvre J.
    Can J Cardiol; 1995 Aug 27; 11 Suppl F():33F-39F. PubMed ID: 7664216
    [Abstract] [Full Text] [Related]

  • 17. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the early period after kidney transplantation.
    Orlić L, Mikolasević I, Sladoje-Martinović B, Bubić I, Pavletić-Persić M, Racki S.
    Coll Antropol; 2013 Sep 27; 37(3):809-14. PubMed ID: 24308221
    [Abstract] [Full Text] [Related]

  • 18. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE, Julius S.
    Am Heart J; 2004 Nov 27; 148(5):747-54. PubMed ID: 15523303
    [Abstract] [Full Text] [Related]

  • 19. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S.
    Acta Med Indones; 2008 Jan 27; 40(1):34-7. PubMed ID: 19054878
    [Abstract] [Full Text] [Related]

  • 20. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
    Onuigbo MA.
    Hemodial Int; 2009 Oct 27; 13 Suppl 1():S24-9. PubMed ID: 19775421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.